USE OF ANTI-TNF THERAPY IS ASSOCIATED WITH INCREASED RISK OF ACUTE CHOLANGITIS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS

被引：0
|
作者：
Kulkarni, Chiraag
Murag, Soumya
Cholankeril, George T.
Fardeen, Touran
Mannalithara, Ajitha
Lerrigo, Robert
Kamal, Ahmad
Ahmed, Aijaz
Goel, Aparna
Sinha, Sidhartha R.
机构：
来源：
GASTROENTEROLOGY | 2021年 / 160卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
351
引用
收藏
页码：S65 / S65
页数：1
相关论文
共 50 条
  • [1] Association of Anti-TNF Therapy With Increased Risk of Acute Cholangitis in Patients With Primary Sclerosing Cholangitis
    Kulkarni, Chiraag
    Murag, Soumya
    Cholankeril, George
    Fardeen, Touran
    Mannalithara, Ajitha
    Lerrigo, Robert
    Kamal, Ahmad
    Ahmed, Aijaz
    Goel, Aparna
    Sinha, Sidhartha R.
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (10) : 1602 - 1609
  • [2] DEMOGRAPHIC AND CLINICAL RISK FACTORS ASSOCIATED WITH ACUTE CHOLANGITIS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
    Medina-Morales, Esli
    Bernal, Romelia Barba
    Ferrigno, Bryan
    Goyes, Daniela
    Sierra, Leandro
    Saberi, Behnam
    Patwardhan, Vilas
    Bonder, Alan
    HEPATOLOGY, 2022, 76 : S1512 - S1513
  • [3] UNIQUE PHENOTYPIC CHARACTERISTICS AND USE OF ANTI-TNF THERAPY IN ULCERATIVE COLITIS PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: A MULTICENTER US EXPERIENCE
    Mousa, Omar Y.
    Wang, Ming-Hsi
    Friton, Jessica
    Raffals, Laura H.
    Leighton, Jonathan A.
    Pasha, Shabana F.
    Picco, Michael F.
    Newberry, Rodney D.
    Faubion, William
    GASTROENTEROLOGY, 2018, 154 (06) : S19 - S20
  • [4] Increased risk of cancer in patients with primary sclerosing cholangitis
    Bave, Aiva Lundberg
    Bergquist, Annika
    Bottai, Matteo
    Warnqvist, Anna
    von Seth, Erik
    Nordenvall, Caroline
    HEPATOLOGY INTERNATIONAL, 2021, 15 (05) : 1174 - 1182
  • [5] Increased risk of cancer in patients with primary sclerosing cholangitis
    Aiva Lundberg Båve
    Annika Bergquist
    Matteo Bottai
    Anna Warnqvist
    Erik von Seth
    Caroline Nordenvall
    Hepatology International, 2021, 15 : 1174 - 1182
  • [6] STATINS PROTECT AGAINST THE RISK OF ACUTE CHOLANGITIS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
    Kulkarni, Chiraag
    Cholankeril, George T.
    Fardeen, Touran
    Rathkey, Joseph K.
    Khan, Raja Samir
    Murag, Soumya
    Lerrigo, Robert
    Kamal, Ahmad
    Ahmed, Aijaz
    Goel, Aparna
    Sinha, Sidhartha R.
    GASTROENTEROLOGY, 2022, 162 (07) : S14 - S14
  • [7] Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis
    Bergquist, Annika
    Montgomery, Scott M.
    Bahmanyar, Shahram
    Olsson, Rolf
    Danielsson, Ake
    Lindgren, Stefan
    Prytz, Hanne
    Hultcrantz, Rolf
    Loof, Lars
    Sandberg-Gertzen, Hanna
    Almer, Sven
    Askling, Johan
    Ehlin, Anna
    Ekbom, Anders
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (08) : 939 - 943
  • [8] DUCTOPENIC REJECTION - INCREASED RISK IN PRIMARY SCLEROSING CHOLANGITIS
    CRIPPIN, JS
    CARLEN, SL
    GOLDSTEIN, RM
    HUSBERG, BS
    KLINTMALM, G
    HEPATOLOGY, 1992, 16 (04) : A276 - A276
  • [9] Risk of waitlist mortality in patients with primary sclerosing cholangitis and bacterial cholangitis
    Goldberg, David S.
    Camp, Amanda
    Martinez-Camacho, Alvaro
    Forman, Lisa
    Fortune, Brett
    Reddy, K. Rajender
    LIVER TRANSPLANTATION, 2013, 19 (03) : 250 - 258
  • [10] Therapy of primary sclerosing cholangitis
    Beuers, U
    Paumgartner, G
    IMMUNOLOGY & LIVER, 2000, 114 : 330 - 337
12345